抗脂抗体与系统性红斑狼中扩散膜出血风险之间的关联:系统性审查和元分析
Mariana González-Treviño1,2, Gabriel Figueroa-Parra1, Jeffrey X Yang1
1Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
Rheumatology (Oxford, England)
|November 19, 2024
概括
抗脂抗体 (aPL) 在患有系统性红斑狼 (SLE) 的患者中显著增加扩散膜出血 (DAH) 的风险. 对于那些患有狼抗凝剂 (LA) 和抗心素IgG抗体的人来说,这种风险特别高.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 系统性红斑狼 (SLE) 是一种复杂的自身免疫性疾病.
- 扩散膜出血 (DAH) 是SLE的严重肺部并发症.
- 抗脂抗体 (aPL) 与APS中的血栓和产科事件有关.
研究的目的:
- 在SLE患者中系统地审查和元分析aPL和DAH之间的关联.
- 量化SLE患者的DAH风险,这些患者具有不同的aPL概况.
主要方法:
- 系统搜索多个数据库 (开始至2024年2月).
- 纳入标准:SLE患者,aPL状态和DAH结果.
- 使用固定效应模型计算赔率比率 (OR) 的元分析.
主要成果:
- 包括9项研究 (7746名SLE患者);26%是aPL阳性,2.1%患有DAH.
- aPL阳性SLE患者的DAH风险增加了1.76倍 (OR=1.76).
- 狼抗凝剂 (LA) 和抗心素IgG阳性与较高的DAH风险显著相关 (分别为OR=1.76和OR=1.62).
- 抗脂综合征 (APS) 诊断增加了DAH的可能性2.46倍 (OR=2.46).
- 抗β2糖蛋白IIgG阳性与DAH没有显著的关联 (OR=0.78).
结论:
- aPL阳性是SLE中DAH的重要风险因素.
- 特定的aPLs,即LA和抗心脂蛋白IgG,特别与DAH的发展有关.
- 这些发现强调了在aPL阳性SLE患者中对DAH的监测的重要性.
相关概念视频
Rh Blood Group
1.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K
Rheumatic Heart Disease I: Introduction
3
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
Genome-wide Association Studies-GWAS
12.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
7
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7


